Navigation Links
American Chemical Society calls green chemistry bill a 'smart step'
Date:9/5/2007

WASHINGTON, D.C., Sept. 5, 2007 The American Chemical Society (ACS) today praised House passage of legislation seeking to improve federal coordination, dissemination and investment in green chemistry research and development (R&D). The Green Chemistry Research and Development Act of 2007 (HR 2850) aims to provide safer, more sustainable technological options to replace traditional products and processes.

H.R. 2850 was introduced in the House on June 25, 2007, by Reps. Phil Gingrey (R-Ga.), Mario Diaz-Balart (R-Fla.), Vernon Ehlers (R-Mich.), Peter Welch (D-Vt.), and David Wu (D-Ore.). On July 11, 2007, the House Committee on Science and Technology passed the bill by unanimous consent, and the bill yesterday passed the full House of Representatives by voice vote. Similar legislation was passed overwhelmingly by the House in each of the last two Congresses, but was not acted on in the Senate.

Green chemistry is the ultimate proof that environmental and economic benefits in chemistry can be optimized simultaneously. The technologies that spin out of this novel research are the seeds that can sustain small business ventures and green corporate practices, said Catherine T. Hunt, Ph.D., ACS President. From reducing and improving pharmaceutical processes, reinventing the home and construction business, to over-coming our climate and energy challenges, green chemistry is proving that economics and environment are not mutually exclusive.

The bill dedicates resources at a number of federal agencies towards green chemistry R&D and improves interagency coordination. By concentrating on sustainable economic practices in the chemical industry, we can move towards a more sustainable vision of the future, Hunt said. In a letter to lead sponsor Gingrey, Hunt praised the interagency program set up by the legislation because it would strengthen the governments role as a true partner in promoting greener technologies.

Under the bill, the Nati
'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...searchers are at work on many scientific and techn...n has recently provided support that totals nearly...wing investigators under the American Recovery and...have been awarded grants for investigation of sola...sor of physics, will enhance the capabilities of N...
(Date:11/20/2009)...hly precise measurements of plasma lipoprotein con...ce spectroscopy (NMR), researchers led by Daniel C... Medical School in Boston, MA, the Framingham Hear...m in Stockholm, Sweden and Oxford, England perform...enome among 17,296 women of European ancestry from...
(Date:11/20/2009)...gton, DC Nov. 20, 2009) Scientists from the Mari...ions of the Naval Research Laboratory (NRL) organi...ientists on an Arctic expedition to initiate metha...ermine the spatial variation of sediment contribut...S. Coast Guard Cutter Polar Sea as a research plat...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2International expedition investigates climate change, alternative fuels in Arctic 2U M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 59318 1U M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 59318 2U M Doctor Working to Get Neurologists in the Game When it Comes to Sports Injuries 59318 3Blue Cross Names Three New Executives 59315 1Blue Cross Names Three New Executives 59315 2Blue Cross Names Three New Executives 59315 3Varian Inc Delivers a Productivity Increase of Up to 100 25 With Its 710 ES Series ICP OES 5406 1Varian Inc Delivers a Productivity Increase of Up to 100 25 With Its 710 ES Series ICP OES 5406 2Varian Inc Delivers a Productivity Increase of Up to 100 25 With Its 710 ES Series ICP OES 5406 3
...nc., a clinical-stage biopharmaceutical company fo...s of epidemic potential, announced today that the ...ropean Medicines Agency (EMEA) independently revie...gencies granted SQ109 orphan drug status for the t... vitro and in vivo activity against drug-susceptib...
...rnational collaboration, more than 200 medical and...his week on the relationship between poverty and h...he Council of Science Editors, includes presentati... webcast live from the National Institutes of Heal...nih.gov/summary.asp?live=6239 , Two of the selec...
...hnology has joined forces with the world,s largest...logies that will provide an economical, green fuel...Bligh today announced the multi-million dollar dea...Bioindustries, supported by the Queensland Governm...nta Centre for Sugarcane Biofuel Development" at Q...
Other Biology News:Sequella receives US and EU orphan drug status for SQ109 for the treatment of TB 2Sequella receives US and EU orphan drug status for SQ109 for the treatment of TB 3200 journals join in theme issues on poverty and human development 2200 journals join in theme issues on poverty and human development 3200 journals join in theme issues on poverty and human development 4200 journals join in theme issues on poverty and human development 5Global deal fuels QUT's world-changing research 2
(Date:11/20/2009)... Latin American countries have an opportunity to t...esearchers from the University of Valencia (UV), w...studied the productive fabric of the Spanish biote...s food and plant sectors have more clout than thos... as applied to food and plants has been overlooked...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Cel...announced today that the Ninth Circuit Court of Ap...ed that CTI should be allowed to pursue all of its...ack to the District Court for trial. CTI filed a ...rd-party reimbursement consultant for CTI,s produc...
(Date:11/19/2009)...SEATTLE, Nov. 19 Omeros ...ited financial results for the third quarter ended...ptember 30, 2009, Omeros reported a net loss of $3...et loss of $7.4 million, or $2.54 per share, for t...September 30, 2009, the Company reported a net los...
(Date:11/19/2009)..., MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNe...ecision Resources find that the leading driver of ...rope is broad-spectrum activity against gram-posit...y of organisms that can cause nosocomial pneumonia...ok primarily for agents that provide appropriate c...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
..., Jan. 13 Cumberland Pharmaceuticals Inc.,is plea...oduct Director. In,this role, Mr. Lee will draw up...ing experience to lead the prospective launch and ... , (Photo: http://www.newscom.com/cgi-bin/pr...ased to welcome Mr. Lee to Cumberland,s management...
...3 /PRNewswire-Asia-FirstCall/ -- American Oriental...he Company"), a leading marketer,distributor and m...cts in,China, today announced that the PRC governm... of China, the Ministry of Finance and the State A...f the company,s subsidiaries, Heilongjiang,Songhua...
... NEW HOPE, Pa., Jan. 13 Jubilant Organosys,Ltd., ...today that its,Bangalore-based subsidiary, Jubilan...artnership with BioLeap, LLC, USA. Under this par...eap,s leading edge computational fragment,based dr...emistry, biology and,crystallography to offer a hi...
Other Biology Technology:PRC Government Grants High-Tech Status to AOBO Subsidiaries 2PRC Government Grants High-Tech Status to AOBO Subsidiaries 3Jubilant and BioLeap Announce New Partnership in Drug Discovery 2Jubilant and BioLeap Announce New Partnership in Drug Discovery 3
Mouse Anti-Guinea Pig T-Cells, Pan Monoclonal Antibody, FITC Conjugated from AbD Serotec
Canine Serum from CHEMICON
...d (40kb), and large plasmid insert (10-20kb) DNAs..... On command 20-50 fold copy amplification for hig...ailable with blue-white screening (pEZ BAC) or tra...t insert stability. Kits include electrocompetent ...
Rabbit Anti-GLYCINE Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: